STOCKS TELEGRAPH

Tag: LEU Stock Price

  • Anticipation Builds As Centrus Energy (LEU) Prepares For Key Uranium Enrichment Briefing

    Anticipation Builds As Centrus Energy (LEU) Prepares For Key Uranium Enrichment Briefing

    Centrus Energy Corp. (NYSE: LEU) shares are witnessing a notable today, rising 8.56% to trade at $45.00 as of the latest market session. This uptick in LEU stock comes in anticipation of a significant event that aims to address critical issues in the uranium enrichment sector.

    Upcoming Briefing at Capitol Hill

    The future of American-owned uranium enrichment capabilities will be the subject of a critical briefing by Centrus Energy on Capitol Hill on Tuesday, September 24. The purpose of the session is to draw attention to the actions that must be taken in order to reinstate the United States as a pioneer in uranium enrichment technology and to rebuild its own supply chain, which has been eclipsed by rival nations like China and Russia.

    Centrus is Planning for Strategic Expansion and Leadership

    Amir Vexler, President and CEO of Centrus, together with executives from other companies in Centrus’ wide-ranging industrial network, will present their plan to improve the American Centrifuge Plant in Piketon, Ohio.

    This expansion is intended to supply enriched uranium in response to requests from the commercial and national security sectors. The initiative seeks to create a collaborative framework, relying on a public-private partnership that will integrate substantial federal funding with private investment and commercial agreements.

    LEU’s Commitment to Future Supply

    The briefing is titled “Rebuilding America’s Uranium Enrichment Capacity: Why it Matters, and How to Get It Done” and will take place in the 2075 Rayburn House Office Building in Washington, DC. Apart from this noteworthy endeavor, Centrus Energy has recently committed to a contingency supply agreement with Korea Hydro & Nuclear Power (KHNP) on the business expansion front.

    This agreement aims to support the construction of new uranium enrichment capacity at the Piketon facility and encompasses a decade-long commitment for deliveries of Low-Enriched Uranium (LEU) to fuel Korea’s reactor fleet.

    To date, Centrus Energy has secured approximately $1.8 billion in contingent sales commitments, underscoring the private sector’s eagerness to establish a robust alternative LEU supply source, contingent upon final agreements and essential public and private investment.

  • The Centrus (LEU) Stock Is Increasing Today: What’s Behind It?

    Centrus Energy Corp. (NYSE: LEU) experienced a remarkable surge of 23.41% during Friday’s early trading session, reaching $43.23 per share at its peak. However, the stock’s volatility eventually settled, with a modest 0.23% increase, closing the last trading session at $35.03.

    In the recently reported second quarter of 2023, Centrus (LEU) disclosed its financial performance. Total revenue for the three months ending June 30, 2023, amounted to $98.4 million, showing a slight decline compared to $99.1 million during the same period in 2022—a decrease of $0.7 million.

    The LEU segment contributed significantly to revenue, generating $87.6 million during the second quarter of 2023, an increase of $2.1 million from the same period in 2022.

    This rise was predominantly driven by a $39.5 million increase in uranium revenue. However, the gain was partially offset by a $37.4 million decrease in SWU revenue, which resulted from a decline in the average price of SWU sold, despite an increase in volume.

    On the other hand, the Technical Solutions segment’s revenue decreased by $2.8 million during the same period. The decline was primarily attributed to the transition from the HALEU Demonstration Contract to the HALEU Operation Contract in late 2022.

    In the second quarter of 2023, the HALEU Operation Contract generated $10.4 million in revenue, compared to $12.1 million generated by the HALEU Demonstration Contract in the same period in 2022.

    Excitingly, Centrus achieved a significant milestone in June, completing its NRC operational readiness review for HALEU production. Following NRC approval, the company gained authorization to possess uranium at its Piketon, Ohio site and to introduce uranium into the cascade of centrifuges it has constructed.

    This progress brings Centrus one step closer to achieving first-of-a-kind HALEU production by the end of 2023, marking the first new U.S.-owned, U.S.-technology enrichment plant to begin production in 70 years.

    Furthermore, LEU is on track to complete its initial HALEU production milestone by the end of this year, marking another critical achievement.

    Additionally, there is promising news in Congress as bipartisan legislation advances to secure a billion-dollar investment in building new U.S. uranium enrichment capacity.

    The future looks bright for Centrus Energy as it progresses toward groundbreaking HALEU production and contributes to the resurgence of U.S.-owned enrichment facilities, a significant milestone in the nation’s nuclear energy history.